Bacterial infectious diseases, caused by bacteria in the body and giving rise to systemic inflammatory response syndrome, are one of the most common diseases in infectious department. Procalcitonin (PCT) is an important clinical index for early diagnosis, assessment of severity of disease, drug selection and prognosis. Current research and clinical progress in these directions are reviewed in the present paper.